Cannabinoids. What do we know?

Join us for the first #SRFwebinar of 2021! "Cognition, behaviour and clinical trials in #SYNGAP1" is at 4:30 pm GMT on Thursday, January 14th, 2021. Register via the button below.

Dr. Stephan Sanders of UCSF presents “SYNGAP1 in the Developing Human Cortex” on Friday, November 6th at 9 AM Pacific.

Dr. Marcelo Coba gave a talk on November 5th at noon Pacific, titled How & why to use human cellular models to study Syngap1. Dr. Coba has SRF grant 20-1 to support organoid work.

Dr. Heather C. Mefford gave a talk on Thursday, October 15th titled SYNGAP1: The road from gene discovery to targeted therapy. Dr. Mefford is a Geneticist and a member of the SRF SAB.

Dr. James Clement gave a talk on Thursday, October 3rd titled Towards therapeutics for Autism Spectrum Disorder using Syngap1 heterozygous mouse model.

Dr. Richard Huganir gave a talk titled Rescue of SynGAP expression in SYNGAP1 Syndrome: Antisense Oligonucleotides (ASOs), small molecules, and viral genetic rescue on September 17th at 9 AM Pacific.

Ms. Brimble — formerly of Stanford Genetics and currently a member of the SRF SAB — gave a talk titled Leveraging technology to improve access to rare disease research on Thursday, August 20th.

Dr. Smith-Hicks gave a talk on August 5th entitled Biomarker Development a path towards clinical trial readiness in SYNGAP1.

Dr. Heller gave a talk about how Epigenetics research will benefit the SynGAP community on Monday, August 3rd, 9 am Pacific.

Dr. Helen Bateup gave a talk titled Loss of SynGAP function in the striatum leads to altered motor & habit learning on July 16th.

Dr. Shilpa Kadam gave a talk titled SYNGAP1 Epilepsy Research: Insights into mechanisms and therapies on July 2nd, 2020.

Dr. Rumbaugh gave a talk titled SYNGAP1 Research Roadmap on June 18th, 2020.

Dr. Holder Presents: SYNGAP1 in Translation: From Deep Phenotyping to Human Neurons